Literature DB >> 937881

Angina-like syndrome with diazoxide therapy for hypertensive crisis.

S A Kanada, D J Kanada, R A Hutchinson, D Wu.   

Abstract

In 14 patients with hypertensive crisis treated with diazoxide, close monitoring of blood pressure, heart rate, and symptoms was performed. Standard 12-lead electrocardiograms were recorded before and after diazoxide. All patients showed a significant fall in blood pressure after drug administration. Seven patients (50%) showed significant ST-T changes after diazoxide. Six patients (43%) developed substernal discomfort demonstrated by substernal pain of tightness. Five patients (35%) had both chest discomfort and ST-T changes. One of these patients with substernal pain and ST elevation had evidence of acute myocardial infarction with serial enzyme studies. In the patients with significant ST-T changes, the average fall in blood pressure was significantly greater than the average fall in blood pressure in the patients without significant ST-T changes. These findings suggest that both ST-T changes and substernal discomfort were due to myocardial ischemia secondary to a sudden severe drop in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937881     DOI: 10.7326/0003-4819-84-6-696

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  Management of more severe cases of hypertension.

Authors:  H Mandin
Journal:  Can Fam Physician       Date:  1985-02       Impact factor: 3.275

Review 2.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 3.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

Review 4.  Vasodilators.

Authors:  T T Zsotér
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

5.  Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713.

Authors:  D Chu; G Cocco; C Strozzi; R Vallini; M Nonato; R Amrein
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

6.  Dangerous antihypertensive treatment.

Authors: 
Journal:  Br Med J       Date:  1979-07-28

Review 7.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

Review 8.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04

9.  Intravenous labetalol in hypertensive patients given by fast and slow injection.

Authors:  R M Pearson; C W Havard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 10.  Current management of hypertensive emergencies.

Authors:  J Y Garcia; D G Vidt
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.